Chronic inflammatory demyelinating polyradiculoneuropathy. 10 Years' experience in a Mexican Centre;Polirradiculoneuropatía crónica inflamatoria desmielinizante. Experiencia de 10 años en un Centro Mexicano

Revista de Neurologia

Volumn 46, Issue 11, 2008, Pages 656-659

  San Juan, O D ^a   Castro Macias J I ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Acquired autoimmune neuropathies; Chronic inflammatory demyelinating neuropathy; Chronic neuropathy; Chronic polyradiculoneuropathy; CIDP; Prognosis

Indexed keywords

PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MALE; NERVE FIBER DEGENERATION;

EID: 45249120190     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4611.2007179     Document Type: Article

References (23)

1. Koller H, Kieseier BC, Jander S, Hartung HP. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 2005; 352: 1343-56.
2. Dalakas MC, Engel WK. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 1981; 9 (Suppl): S134-45.
3. Barohn RJ, Kissel JT,Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989; 46: 878-84.
4. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP): report from an ad hoc subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41: 617-8.
5. Connolly AM. Chronic inflammatory demyelinating polyneuropathy in childhood. Pediatr Neurol 2001; 24: 177-82.
6. Koul R, Chacko A, Javed H, Al-Hinai K, Zachariah M, Bulusu S, et al. A profile of childhood neuropathies at a university hospital in Oman. Saudi Med J 2002; 23: 450-6.
7. McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999; 46: 910-3.
8. Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 1999; 66: 677-80.
9. Barohn RJ, Saperstein DS. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Semin Neurol 1998; 18: 49-61.
10. Rajabally YA, Jacob S, Abbott RJ. Clinical heterogeneity in mild chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 2006; 13: 958-62.
11. Corona-Vázquez T, Campillo-Serrano C, López M, Mateos-G JH, Soto-Hernández JL. The neurologic diseases. Gac Med Mex 2002; 138: 533-46.
12. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001; 24: 311-24.
13. Latov N. Diagnosis of CIDP. Neurology 2002; 59 (Suppl 6): S2-6.
14. Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology 2003; 60 (Suppl 3): S8-15.
15. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. Brain 1987; 110: 1617-30.
16. Bouchard C, Lacroix C, Plante V, Adams D, Chedru F, Guglielmi JM, et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999; 52: 498-503.
17. Rotta FT, Sussman AT, Bradley WG, Ram-Ayyar D, Sharma KR, Shebert RT. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2000; 173: 129-39.
18. Jann S, Beretta S, Bramerio MA. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment. Muscle Nerve 2005; 32: 351-6.
19. Kuwabara S, Ogawara K, Misawa S, Mori M, Hattori T. Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2002; 72: 37-42.
20. Cocito D, Durelli L, Isoardo G. Different clinical, electrophysiological and immunological features of CIDP associated with paraproteinaemia. Acta Neurol Scand 2003; 108: 274-80.
21. Simmons Z, Albers JW, Bromberg MB, Feldman EL. Long-term followup of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain 1995; 118 (Pt 2): 359-68.
22. Uncini A, Di Muzio A, De Angelis MV, Gioia S, Lugaresi A. Minimal and asymptomatic chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 1999; 110: 694-8.
23. Pascual-Pascual SI. Aspectos actuales de las neuropatías inflamatorias agudas y crónicas. Síndrome de Guillain-Barré y polineuritis crónica inflamatoria desmielinizante. Rev Neurol 2002; 35: 269-76.